Form 4 for ABT Abbott Laboratories
Accepted 2025-05-02 00:00:00 ET · period of report 2025-04-30 · accession 0001415889-25-011837 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-02 | 2025-04-30 | ABT | Blount Sally E. | Dir | S - Sale | $129.66 | -2,600 | 34.1K | -7% | -$337.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2025-04-30 | S | D | 2,600 | $129.66 | 34,058 | D | — | — |